CD8A and neoplasm: were among the first to report that high-dose radiotherapy (15-25 Gy×1) could enhance the activation of immune cells in TDLNs of advanced tumours, resulting in activated CD8+ T cells that not only targeted primary tumours but also eliminated distant metastases in some cases.